Compare Stocks › ABBV vs JKHY

AbbVie Inc. (ABBV) vs Jack Henry & Associates, Inc. (JKHY): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. JKHY is fairly valued at $161, with an intrinsic value of $169 and a margin of safety of 4%. Of the two, JKHY has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
JKHY
Jack Henry & Associates, Inc.
$161.34

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
JKHY
  • ★Jack Henry & Associates, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • ★Jack Henry & Associates, Inc. scores 92/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 42.6% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
JKHY

    Key Valuation Metrics

    Learn more →
    ABBV
    JKHY
    Valuation
    N/A
    Free Cash Flow
    $506.51M
    N/A
    FCF Yield
    4.48%
    50.67
    Trailing P/E
    23.11
    18.24
    Forward P/E
    20.37
    Quality & Moat
    29.08%
    ROIC
    21.24%
    N/A
    ROE
    24.04%
    73.72%
    Gross Margin
    43.90%
    0.60
    PEG Ratio
    1.96
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    0.03
    N/A
    Interest Coverage
    N/A
    2.03
    Net Debt / EBITDA
    0.09
    2.35%
    Dividend Yield
    1.51%
    ABBV: 5Ties: 1JKHY: 2
    ABBVJKHY

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    JKHY

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    JKHY
    $-0.71
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $849.4M
    Δ Market Cap
    $-606.5M
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    71.5% Overvalued
    Price is 71.5% above estimated fair value
    Current Price: $294.89
    Fair Value: $172.00
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    JKHY
    4.4% Margin of Safety
    Price is 4.4% below estimated fair value
    Current Price: $161.34
    Fair Value: $168.74
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    Requires positive FCF to compute implied growth rate.

    JKHY

    What growth rate is the market pricing in at $161?

    +9.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +9.3%

    The market implies +9.4% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +9.3%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    JKHY
    92/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    JKHY
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
    No. of Institutional Holders5,303
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    JKHY
    Insiders 0.6%Institutions 102.4%
    No. of Institutional Holders1,010
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    JKHY
    0
    Buys (3M)
    2
    Buys (12M)
    Total value (12M): $317,135
    ADELSON GREGORY R.
    Chief Executive Officer
    $266,840
    @ $133.42 · 2026-05-14
    CARSLEY MIMI
    Chief Financial Officer
    $50,295
    @ $134.12 · 2026-05-14
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    1
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $18.92M
    DONOGHOE NICHOLAS
    Officer
    $8.18M
    @ $250.00 · 2026-08-14
    PURDUE DAVID RYAN
    Officer
    $1.22M
    @ $233.56 · 2026-03-04
    SIATIS PERRY C.
    General Counsel
    $4.38M
    @ $234.39 · 2026-03-02
    SIATIS PERRY C.
    General Counsel
    $5.15M
    @ $230.00 · 2026-02-25
    SALEKI-GERHARDT AZITA
    Chief Operating Officer
    $8.41M
    @ $198.42 · 2025-08-12
    DONOGHOE NICHOLAS
    Officer
    $2.64M
    @ $198.51 · 2025-08-05
    STEWART JEFFREY RYAN
    Officer
    $12.36M
    @ $210.08 · 2025-03-31
    REENTS SCOTT T.
    Chief Financial Officer
    $3.75M
    @ $212.34 · 2025-03-14
    GONZALEZ RICHARD A
    Director
    $20.26M
    @ $205.45 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $4.47M
    @ $210.45 · 2025-03-03
    SIATIS PERRY C.
    General Counsel
    $5.82M
    @ $208.69 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $6.07M
    @ $202.90 · 2025-02-26
    BUCKBEE KEVIN K
    Officer
    $3.85M
    @ $203.41 · 2025-02-26
    SIATIS PERRY C.
    General Counsel
    $1.14M
    @ $197.90 · 2025-02-20
    BUCKBEE KEVIN K
    Officer
    $310,032
    @ $172.24 · 2024-12-16
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    JKHY
    0
    Sells (3M)
    2
    Sells (12M)
    Total value (12M): $3.53M
    FOSS DAVID B
    Director
    $3.50M
    @ $174.92 · 2025-12-01
    MCLACHLAN SHANON G.
    Chief Operating Officer
    $36,508
    @ $160.83 · 2025-11-10
    FOSS DAVID B
    Director
    $966,878
    @ $167.28 · 2025-08-04
    SWEARINGEN RENEE ANN
    Officer
    $180,891
    @ $179.10 · 2025-05-13
    MCLACHLAN SHANON G.
    Chief Operating Officer
    $44,137
    @ $179.42 · 2025-05-13
    FOSS DAVID B
    Officer and Director
    $2.71M
    @ $180.74 · 2025-05-12
    MORGAN CRAIG KEITH
    General Counsel
    $900,816
    @ $180.16 · 2025-05-12
    FOSS DAVID B
    Officer and Director
    $3.22M
    @ $171.32 · 2024-11-19
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(72/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    JKHY
    FearGreed
    😐Neutral(55/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    ⚪Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
    JKHY
    ⚪Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (55)
    View ABBV Full AnalysisView JKHY Full Analysis

    Frequently Asked Questions: ABBV vs JKHY

    Is AbbVie Inc. or Jack Henry & Associates, Inc. more undervalued in 2026?▼

    Based on our discounted cash flow model, JKHY trades at a 4.4% margin of safety (intrinsic value $169 vs. price $161), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

    Which stock has a wider economic moat, AbbVie Inc. or Jack Henry & Associates, Inc.?▼

    JKHY scores 92/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is AbbVie Inc. in financial distress?▼

    ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. JKHY scores 9.4 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, AbbVie Inc. or Jack Henry & Associates, Inc.?▼

    ABBV earns 29.1% ROIC versus JKHY's 21.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, AbbVie Inc.'s or Jack Henry & Associates, Inc.'s?▼

    JKHY's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). JKHY has raised its dividend for 3 consecutive years.

    ABBV vs JKHY: Which Is the Better Buy in 2026? | SafetyMargin.io